Poltreg S.A.

Warsaw Stock Exchange PTG.WA

Poltreg S.A. Total Assets for the year ending December 31, 2023: USD 32.23 M

Poltreg S.A. Total Assets is USD 32.23 M for the year ending December 31, 2023, a 14.52% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.

Poltreg S.A. Total Assets for the year ending December 31, 2022 was USD 28.14 M, a 4.25% change year over year.
Poltreg S.A. Total Assets for the year ending December 31, 2021 was USD 27.00 M, a 520.77% change year over year.
Poltreg S.A. Total Assets for the year ending December 31, 2020 was USD 4.35 M, a 141.44% change year over year.
Poltreg S.A. Total Assets for the year ending December 31, 2019 was USD 1.80 M, a -35.52% change year over year.

Key data

Date	Total Assets	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity

Warsaw Stock Exchange: PTG.WA

Poltreg S.A.

CEO	Mr. Piotr Trzonkowsk
IPO Date	Nov. 23, 2021
Location	Poland
Headquarters	Waly Piastowskie 1 lok. 1508
Employees	25
Sector	Healthcare
Industries Biotechnology Clinical Trials Pharmaceuticals Vaccines

Description

Poltreg S.A., a biotechnology company, develops therapies for autoimmune diseases using T-regulatory cells. It engages in the research and development of therapies for the treatment of type 1 diabetes in children and in multiple sclerosis. The company is based in Gdansk, Poland.

Key trends

Past 5 years